U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

The American Diabetes Association Scientific Sessions, held in June, featured cutting-edge science, from new agents to treat ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

A new European obesity framework adds waist-to-height ratio and comorbidities to BMI assessment. Could this help identify ...

Obesity before pregnancy, not just during, may shape a child’s brain and raise the risk of autism spectrum disorder, a new ...

Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: ...

Lil Terrio has given fans a major life update and advice on how to push through adversity. On Thursday, the 17-year-old ...